Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
Neurotoxicity Research|June 25, 2009
Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy studySanjay Kasture, Stefania Vinci, Federico Ibba, et al.
Analytical and Bioanalytical Chemistry|December 1, 2009
Determination of naltrexone and 6beta-naltrexol in human blood: comparison of high-performance liquid chromatography with spectrophotometric and tandem-mass-spectrometric detectionSonja Brünen, Ralf Krüger, Susann Finger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 25, 2010
The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot studyAndré Tadić, Stefanie Wagner, Konrad Friedrich Schlicht, et al.
Dementia and Geriatric Cognitive Disorders|September 18, 2010
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's diseaseIgor Yakushev, Peter Bartenstein, Thomas Siessmeier, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2006
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatmentBoldizsár Czéh, Jeanine I H Müller-Keuker, Rafal Rygula, et al.
Macromolecular Bioscience|January 15, 2016
Amphiphilic Copolymers Shuttle Drugs Across the Blood-Brain BarrierMirjam Clemens-Hemmelmann, Christiane Kuffner, Verena Metz, et al.
European Journal of Clinical Pharmacology|April 11, 2019
Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic databaseGeorgios Schoretsanitis, Ekkehard Haen, Gerhard Gründer, et al.
International Clinical Psychopharmacology|July 21, 2018
Sex and body weight are major determinants of venlafaxine pharmacokineticsGeorgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, et al.
Psychopharmacology|December 31, 2010
Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice modelLouise Karlsson, Christoph Hiemke, Björn Carlsson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2010
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoproteinLouise Karlsson, Ulrich Schmitt, Martin Josefsson, et al.
Pageof 26